The DOI matches its Crossref record.
Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
Open accessAbstract
To the Editor—We appreciate the comments from Abers and Musher [1] in response to our recent article describing the association between procalcitonin and etiology in community-acquired pneumonia [2]. We agree with them that withholding antibiotics from a patient with bacterial pneumonia has the potential to harm the patient and should be avoided. Based on the principle of never missing bacterial pneumonia, nearly all adults with pneumonia diagnosed in the United States are empirically treated with antibiotics [3, 4]. However, many adults with pneumonia seem to have nonbacterial disease [2, 3], meaning that many do not benefit from antibiotics. Owing to the current limitations in direct pathogen testing, the cause of pneumonia typically cannot be identified at the time of diagnosis, and, in many cases, it cannot be identified at all [3, 4]. Hence, the current management paradigm recommends empiric antibiotics to cover the most likely infecting bacteria [4]. Many investigators are seeking to improve this management paradigm by improving diagnostics and developing strategies to safely withhold antibiotics from patients with pneumonia who have a very low risk of bacterial infection. Although no definitive approach for safely withholding antibiotics has been developed, investigators have outlined several risk factors associated with higher or lower probability of bacterial pneumonia. Both serum procalcitonin concentration [2] and certain clinical features, such as those outlined by Abers and Musher [1], can be used to discriminate between patients with a high versus a low probability of having bacterial pneumonia. However, none of the risk factors seem to be a strong enough predictor of nonbacterial disease for clinicians to withhold antibiotics based solely on a single risk factor. In this context, we believe that procalcitonin measurements can be used to complement algorithms for pneumonia treatment, probably in combination with other biomarkers and clinical characteristics. An advantage of procalcitonin concentrations over clinical characteristics is their objective nature. Whereas a specific procalcitonin value can be consistently interpreted among clinicians, more subjective variables, such as “acute deterioration,” “dense segmental or lobar consolidation,” and “hyperacute presentation,” may be applied somewhat differently by different providers. Disadvantages of using procalcitonin concentrations include the cost and time required to obtain results from the laboratory. In their letter, Abers and Musher [1] described several clinical characteristics they have found useful in distinguishing bacterial from nonbacterial pneumonia. Unfortunately, we did not collect the necessary data in the Etiology of Pneumonia in the Community (EPIC) study [2, 3] to evaluate the scoring system the authors outline [1; Table 1]. Prevalence of Bacterial Pathogens and Serum Procalcitonin Concentration in 1735 Adults in the Etiology of Pneumonia in the Community Study Hospitalized With Community-Acquired Pneumonia, Stratified by Clinical Variables Described by Abers and Musher [1] Abbreviations: IQR, interquartile range; WBC, white blood cell. aRow percentages. Prevalence of Bacterial Pathogens and Serum Procalcitonin Concentration in 1735 Adults in the Etiology of Pneumonia in the Community Study Hospitalized With Community-Acquired Pneumonia, Stratified by Clinical Variables Described by Abers and Musher [1] Abbreviations: IQR, interquartile range; WBC, white blood cell. aRow percentages. Abers and Musher [1] also report that, in their experience, patients without any of the following 5 clinical characteristics have a low risk of bacterial pneumonia and a low serum procalcitonin concentrations (<0.25 ng/mL): temperature ≥99.4°F (37.4 C), rigors, white blood cell (WBC) count >12000/μL, bands ≥3%, and a dense segmental or lobar consolidation. We did not collect band count as part of the EPIC study, but we were able to evaluate the other 4 characteristics. We used the initial temperature and WBC count recorded after hospital presentation to define temperature ≥99.4°F and WBC count >12000/μL. Rigors were defined as a report of chills during the current illness by the patient or caretaker during the study interview at enrollment. Dense segmental or lobar consolidation was defined as segmental or lobar consolidation identified on a chest radiograph by a study-dedicated thoracic radiologist; we did not ask the radiologists in our study to classify consolidation as light versus dense. Among 1735 patients, 1625 (93.7%) had ≥1 of these 4 characteristics, and 236 (13.6%) had a bacterial pathogen detected. Each of these 4 characteristics (temperature ≥ 99.4° F, rigors, WBC >12,000/uL, and dense segmental or lobar consolidation) were individually associated with higher risk of a bacterial pathogen and high procalcitonin concentrations (Table 1). However, the classification of patients as low or high risk for bacterial disease based on the pr
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1581st · Cited by 3,657
Influenza virus-related critical illness: pathophysiology and epidemiology
Kalil, A. C., & Thomas, P. G. (2019) · Critical Care · doi:10.1186/s13054-019-2539-x · Cited by 524
Community-acquired Pneumonia and Hospital-acquired Pneumonia
Lanks, C. W., Musani, A. I., & Hsia, D. W. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.12.008 · Cited by 297
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
Póvoa, P., Coelho, L., Dal-Pizzol, F., Ferrer, R., Huttner, A., Conway Morris, A., Nobre, V., Ramirez, P., Rouze, A., Salluh, J., et al. (2023) · Intensive Care Medicine · doi:10.1007/s00134-022-06956-y · Cited by 292
Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta-analysis
Kamat, I. S., Ramachandran, V., Eswaran, H., Guffey, D., & Musher, D. M. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz545 · Cited by 272
Metadata
- Authors
- Self, W. H., Wunderink, R. G., Jain, S., Edwards, K. M., Grijalva, C. G., & Etiology of Pneumonia in the Community (EPIC) Study Investigators
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-01-18
- Volume
- 66
- Issue
- 10
- Pages
- 1640-1641
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2606248635
- Cited by
- 178
- References
- 0
- FWCI
- 15.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia. https://app.cochat.ai/papers/10.1093/cid/cix1090
- The paper
- Self, W. H., Wunderink, R. G., Jain, S., Edwards, K. M., Grijalva, C. G., & Etiology of Pneumonia in the Community (EPIC) Study Investigators. (2018). Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia. Clinical Infectious Diseases. https://doi.org/10.1093/cid/cix1090
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.